Empaveli Injection, Solution
Product Images NDC 73606-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Empaveli (NDC 73606-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apellis Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Pegcetacoplan 01)

Chemical Structure (Pegcetacoplan 01)
FDA Label Image

Figure 1 (Pegcetacoplan 02)

Figure 1 (Pegcetacoplan 02)
FDA Label Image

Figure A (Pegcetacoplan 03)

Figure A (Pegcetacoplan 03)
FDA Label Image

Figure B (Pegcetacoplan 04)

Figure B (Pegcetacoplan 04)
FDA Label Image

Figure C (Pegcetacoplan 05)

Figure C (Pegcetacoplan 05)
FDA Label Image

Figure D (Pegcetacoplan 06)

Figure D (Pegcetacoplan 06)
FDA Label Image

Figure E (Pegcetacoplan 07)

Figure E (Pegcetacoplan 07)
FDA Label Image

Figure F (Pegcetacoplan 08)

Figure F (Pegcetacoplan 08)
FDA Label Image

Figure G (Pegcetacoplan 09)

Figure G (Pegcetacoplan 09)
FDA Label Image

Figure H (Pegcetacoplan 10)

Figure H (Pegcetacoplan 10)
FDA Label Image

Figure I (Pegcetacoplan 11)

Figure I (Pegcetacoplan 11)
FDA Label Image

Figure J (Pegcetacoplan 12)

Figure J (Pegcetacoplan 12)
FDA Label Image

Figure K (Pegcetacoplan 13)

Figure K (Pegcetacoplan 13)
FDA Label Image

Figure L (Pegcetacoplan 14)

Figure L (Pegcetacoplan 14)
FDA Label Image

Figure M (Pegcetacoplan 15)

Figure M (Pegcetacoplan 15)
FDA Label Image

Figure N (Pegcetacoplan 16)

Figure N (Pegcetacoplan 16)
FDA Label Image

Figure O (Pegcetacoplan 17)

Figure O (Pegcetacoplan 17)
FDA Label Image

Figure P (Pegcetacoplan 18)

Figure P (Pegcetacoplan 18)
FDA Label Image

Principal Display Panel (1,080 mg/20 mL Vial Carton)

Principal Display Panel (1,080 mg/20 mL Vial Carton)
This is a medication guide for the subcutaneous infusion of Empaveli, which is an injection that contains 1,080mg/20mL (54mg/mL) of pegcetacoplan. The medication is available in a single-dose vial and the unused portion should be discarded. The drug must be refrigerated between 2°C-8°C (36°F-46°F) and removed from the refrigerator at least 30 minutes before use. The vial contains pegcetacoplan, Sobitol, glacial acetic acid, sodium acetate trinydrate, and Water for Injection, USP. Empaveli may also contain sodium hydroxide and/or additional glacial acetic acid for adjustment to a target pH of 5.0. NDC 73606-010-01 is the National Drug Code for this medication. However, the beginning text is not-available as it does not correspond to any medical data.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.